C. Karikari

发表

Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice

Joshua T. Mendell, O. Kent, A. Maitra, 2011, Molecular Cancer Therapeutics.

A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

A. Maitra, A. Maitra, Nathaniel R. Campbell, 2012, Oncotarget.

The Ape‐1/Ref‐1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: Therapeutic implications in tumor angiogenesis

A. Maitra, H. Handa, R. Anders, 2009, Journal of cellular physiology.

Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts

C. Rudin, J. Minna, A. Maitra, 2011, Cancer biology & therapy.

Inactivation of BRCA2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice: A mouse model of familial pancreatic cancer.

G. Feldmann, A. Maitra, M. dal Molin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.

Robert Tibshirani, Tina Hernandez-Boussard, Jonathan R Pollack, 2005, Neoplasia.

linical Development temic Administration of Polymeric Nanoparticle-apsulated Curcumin ( NanoCurc ) Blocks Tumor Growth Ther Metastases in Preclinical Models of Pancreatic Cancer

Bisht, G. Feldmann, A. Maitra, 2010 .

33rd Annual Meeting of the Pancreatic Society of Great Britain and Ireland. October 30–31, 2008, Derby, UK

D. Sahani, N. Malats, F. Real, 2009, Pancreatology (Print).

33rd Annual Meeting of the Pancreatic Society of Great Britain and Ireland. October 30–31, 2008, Derby, UK

D. Sahani, N. Malats, F. Real, 2009, Pancreatology (Print).

The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma

E. Montgomery, G. Riggins, J. Eshleman, 2010, Cancer biology & therapy.

Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma

R. Hruban, A. Maitra, Seung‐Mo Hong, 2010, Pancreatology.

Allele-specific expression in the germline of patients with familial pancreatic cancer: An unbiased approach to cancer gene discovery

Alison P. Klein, Raimond L. Winslow, Marina Bibikova, 2008, Cancer biology & therapy.

Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission

A. Scott, J. Gyapong, S. Sackey, 2005, Tropical medicine & international health : TM & IH.

Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1

D. Rakheja, A. Pandey, Mansher Singh, 2010, Medical Oncology.

Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.

C. Iacobuzio-Donahue, M. Mullendore, G. Feldmann, 2007, Cancer research.

Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer

G. Feldmann, A. Maitra, Seung‐Mo Hong, 2010, Molecular Cancer Therapeutics.

Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models

G. Feldmann, A. Maitra, M. Hidalgo, 2011, Cancer biology & therapy.

The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.

L. Cope, A. Maitra, L. Resar, 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas.

G. Feldmann, A. Maitra, N. Katsanis, 2011, Neoplasia.

An In vivo Platform for Translational Drug Development in Pancreatic Cancer

R. Hruban, J. Eshleman, C. Iacobuzio-Donahue, 2006, Clinical Cancer Research.

Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer

Manuel Hidalgo, Jonathan R Pollack, Karen Matsukuma, 2011, Proceedings of the National Academy of Sciences.

Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer

K. Lee, G. Feldmann, A. Maitra, 2009, Pancreatology.

Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer

M. van de Rijn, J. Pollack, A. Maitra, 2008, PLoS genetics.

SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer

M. van de Rijn, J. Pollack, A. Maitra, 2011, PloS one.

A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists

C. Rudin, A. Maitra, Seung‐Mo Hong, 2011, Molecular Cancer Therapeutics.

An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer

M. Mullendore, G. Feldmann, A. Maitra, 2008, Molecular Cancer Therapeutics.

Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer

R. Hruban, A. Maitra, A. Jimeno, 2011, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer

R. Hruban, A. Maitra, A. Jimeno, 2011 .

In vivo and in vitro Propagation of Intraductal Papillary Mucinous Neoplasms

M. Kamiyama, R. Hruban, J. Eshleman, 2010, Laboratory Investigation.

Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein

Clemencia Pinilla, Indrajit Roy, Dinesh Rakheja, 2007, Molecular Cancer Therapeutics.

Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

M. Mullendore, G. Feldmann, A. Maitra, 2008, Gut.

Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice

Jun O. Liu, M. Kamiyama, R. Hruban, 2013, Clinical Cancer Research.

Mitochondrial DNA Mutations in Pancreatic Cancer

M. Mullendore, G. Feldmann, A. Maitra, 2006, International journal of gastrointestinal cancer.

Cancer Therapy : Preclinical Personalized Chemotherapy Pro fi ling Using Cancer Cell Lines from Selectable Mice

M. Kamiyama, R. Hruban, J. Eshleman, 2013 .

Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.

J. Eshleman, P. Argani, A. Maitra, 2009, The Journal of molecular diagnostics : JMD.

The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target

G. Feldmann, A. Maitra, Pamela Leal-Rojas, 2009, Cancer biology & therapy.

Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers

J. Eshleman, P. Argani, M. Mullendore, 2005, Molecular Cancer Therapeutics.

Inactivation of Brca2 cooperates with Trp53R172H to induce invasive pancreatic ductal adenocarcinomas in mice

G. Feldmann, A. Maitra, M. dal Molin, 2011, Cancer biology & therapy.

In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities

M. Mullendore, G. Feldmann, A. Maitra, 2008, Molecular Cancer Therapeutics.

Sex-specific development of cortical monoamine levels in mouse.

S. Connell, C. Karikari, C. Hohmann, 2004, Brain research. Developmental brain research.

A prospective validation of a direct tumor xenograft model in pancreatic ductal adenocarcinoma (PDA)

J. Cameron, R. Hruban, A. Maitra, 2008 .